vimarsana.com

Biopharma Closecurlyquote News Today : Breaking News, Live Updates & Top Stories | Vimarsana

2022-12-14 | NDAQ:GTBP | Press Release | GT Biopharma Inc

(2022-12-14 | NDAQ:GTBP) GT Biopharma Names Dr. Jeff Miller as Consulting Chief Medical Officer

United statesBiopharma closecurlyquoteJeff millerCorey davisMiller closecurlyquoteMichael breenAmerican society of clinical investigationMiller laboratoryGlobe newswire gt biopharma incCompany closecurlydoublequoteResearch developmentExchange commissionMasonic comprehensive cancer centerAmerican association of immunologistsAmerican society of hematologyUniversity of minnesota closecurlyquote

2022-09-08 | NDAQ:GTBP | Press Release | GT Biopharma Inc

(2022-09-08 | NDAQ:GTBP) GT Biopharma to Participate in the H.C. Wainwright 24th Annual Global Investment Conference in September

Biopharma closecurlyquoteHc wainwright closecurlyquoteCorey davisExchange commissionGlobe newswire gt biopharma incUniversity of minnesotaCompany presentationGt biopharma incAnnual global investment conferenceLotte new yorkHealthcare 37Biotechnology 121Diagnostics research 128Usa 8Biotechnology 70569

2022-06-10 | NDAQ:GTBP | Press Release | GT Biopharma Inc

(2022-06-10 | NDAQ:GTBP) GT Biopharma Presents Preclinical Data Demonstrating Second-Generation CD19 Targeting Tri-Specific Killer Engager (TriKE®) Driving Robust NK Cell Function Against B Cell Malignancies at EHA 2022 Congress

United statesBiopharma closecurlyquoteCorey davisJeff miller closecurlyquoteGregory berkGlobe newswire gt biopharma incEuropean hematology associationCompany closecurlydoublequoteExchange commissionCompany closecurlyquoteCongress poster detailsUniversity of minnesotaGt biopharma incAmerican cancer societyTri specific killer engager drives robustFunction againstb cell malignancies

vimarsana © 2020. All Rights Reserved.